Valisure Can't Get Fees For Quashed Subpoena In Zantac MDL

By Mike Curley (May 19, 2022, 5:33 PM EDT) -- A Florida magistrate judge on Thursday denied medical testing laboratory Valisure LLC's bid for attorney fees associated with responding to a quashed subpoena in multidistrict litigation over allegations that the heartburn drug Zantac contains a carcinogen, saying defendants in the case had justification for seeking the documents.

In the order, U.S. Magistrate Judge Bruce E. Reinhart said while the subpoena was quashed, at the time Sanofi SA and Boehringer Ingelheim Pharmaceuticals Inc. served the subpoenas, they had reason to believe that the plaintiffs in the MDL were going to rely on testing that Valisure had done as evidence.

Sanofi and Boehringer...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!